Pasar al contenido principal

TERAPIA METABOLICA DEL CANCER: SUPRESION TUMORAL INDUCIDA POR DESREGULACION DE GLUTAMINASA

RTI2018-096866-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE MALAGA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression

  • Guillén-Pérez, Yolanda María
  • Ortiz-Ruiz, María Jesús
  • Márquez, Javier
  • Pandiella, Atanasio
  • Esparís-Ogando, Azucena
Many of the biological processes of the cell, from its structure to signal transduction, involve protein–protein interactions. On this basis, our aim was to identify cellular proteins that interact with ERK5, a serine/threonine protein kinase with a key role in tumor genesis and progression and a promising therapeutic target in many tumor types. Using affinity chromatography, immunoprecipitation, and mass spectrometry techniques, we unveiled an interaction between ERK5 and the mitochondrial glutaminase GLS in pancreatic tumor cells. Subsequent co-immunoprecipitation and immunofluorescence studies supported this interaction in breast and lung tumor cells as well. Genetic approaches using RNA interference techniques and CRISPR/Cas9 technology demonstrated that the loss of ERK5 function led to increased protein levels of GLS isoforms (KGA/GAC) and a concomitant increase in their activity in tumor cells. It is well known that the tumor cell reprograms its intermediary metabolism to meet its increased metabolic needs. In this sense, mitochondrial GLS is involved in the first step of glutamine catabolism, one of the main energy sources in the context of cancer. Our data suggest that ERK5 contributes to the regulation of tumor cell energy metabolism via glutaminolysis., This research was funded by the Instituto de Salud Carlos III (ISCIII), grant number PI15/01180 co-founded by ERDF, “A way to make Europe”, and grant number PI19/00840 co-funded by the European Union to A.E.-O. Work in A.P.’s laboratory was supported by the Ministry of Economy and Competitiveness of Spain (PID2020-115605RB-I00); the Instituto de Salud Carlos III through CIBERONC; Junta de Castilla y León (CSI146P20); and the CRIS Cancer Foundation. Work carried out in our laboratories received support from the European community through the Regional Development Funding Program (ERDF) “A way to make Europe”. Work carried out in J.M.’s laboratory received support from grant RTI2018-096866-B-I00 (to J.M.) from the Ministry of Science, Innovation and Universities and from grant PID2022-140388OB-I00 (to J.M. Matés), co-funded by the European Union and the Ministry of Science and Innovation., Peer reviewed